Tradestie Institutional Equity Comparison Engine

ACHV vs LCTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACHV Overall Edge

ACHV Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Achieve Life Sciences, Inc. (ACHV) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while LCTX counters with relative strength in Valuation. Fundamentally, ACHV trades at 35.3x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus LCTX at 30.7x Forward P/E and -280.3% operating margin (-61.0% YoY). In options structure, ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro) against LCTX sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LCTX
ACHV 35.3x vs LCTX 30.7x Fwd P/E
Growth & Margin Winner ACHV
Op Margin 0.0% vs -280.3% ยท YoY +0.0% vs -61.0%
Momentum & Technical Winner ACHV
1Y +43.0% vs -54.9% ยท 52W Pos 69% vs 0%
Options & Structure Winner ACHV
BREAKOUT (23rd %ile IV) vs BREAKDOWN (<1st %ile IV)
ACHV NASDAQ
Achieve Life Sciences, Inc.
In Vitro & In Vivo Diagnostic Substances
$6.78
+0.89% 1D
Market Cap $692.8M
1M Return -8.5%
1Y Return +43.04%
Forward P/E 35.3x
Unified AI Score
56.6 / 100 HOLD
Tech 66.0 Fund 58.0 Flow 57.0 Mom 58.9
LCTX NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.77
-5.87% 1D
Market Cap $207.4M
1M Return -21.63%
1Y Return -54.86%
Forward P/E 30.7x
Unified AI Score
54.9 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 72.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACHV +43.04% LCTX -54.86% Spread: +93.78 pp (ACHV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACHV TTM Op. Margin: 0.0% LCTX TTM Op. Margin: -280.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACHV vs LCTX. Trailing 12-month operating profitability (ACHV 0.0% vs LCTX -280.3%) and valuation multiples (ACHV 35.3x vs LCTX 30.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACHV (6) vs LCTX (4)
Institutional Metric ACHV LCTX Criterion Row Winner
Market Capitalization Scale $692.8M $207.4M Larger Scale ACHV
Trailing P/E Ratio Valuation 35.3x 30.7x Lower Multiple LCTX
Forward P/E Ratio Valuation 35.3x 30.7x Lower Multiple LCTX
Revenue Growth (YoY) Growth +0.0% -61.0% Higher Growth ACHV
Operating Margin (TTM) Profitability 0.0% -280.3% Higher Margin ACHV
Net Profit Margin Profitability 0.0% 16.2% Higher Margin LCTX
Return on Equity (ROE) Capital Efficiency -845.0% 4.3% Higher ROE LCTX
52-Week Range Position Momentum 69% ($3โ€“$9) 0% ($1โ€“$2) Stronger Trend ACHV
Beta / 30D Volatility Risk Regime 1.73ฮฒ ยท 62% Vol 1.39ฮฒ ยท 79% Vol Lower Realized Risk ACHV
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 54.9 / 100 (HOLD) Higher Composite ACHV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACHV vs LCTX Buy Guide
ACHV BREAKOUT
125d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live ACHV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LCTX BREAKDOWN
7d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live LCTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACHV nor LCTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.